Neuren Pharmaceuticals | NEU - Current Liabilities

Stock Price
12.35
Daily Change
-0.44 -3.44%
Monthly
-1.04%
Yearly
-2.22%
Q2 Forecast
12.55

Neuren Pharmaceuticals reported AUD4.34M in Current Liabilities for its fiscal semester ending in December of 2025.





Current Liabilities Change Date
Akebia Therapeutics USD 173.88M 10.95M Mar/2026
Alaunos Therapeutics USD 595K 218K Mar/2026
Avita Medical AUD 62.68M 77K Dec/2025
Clinuvel Pharmaceuticals AUD 17.85M 9.36M Dec/2025
Dianthus Therapeutics USD 38.28M 7.55M Mar/2026
Genetic Signatures AUD 4.78M 680K Dec/2025
Ionis Pharmaceuticals USD 717M 66M Mar/2026
Medical Developments International AUD 5.56M 2.26M Dec/2025
Neuren Pharmaceuticals AUD 4.34M 3.58M Dec/2025
Organon & Co USD 2.5B 110M Mar/2026
Paradigm Biopharmaceuticals AUD 16.6M 13.37M Dec/2025
PYC Therapeutics AUD 11.01M 1.31M Dec/2025
Starpharma Holdings AUD 4.61M 614K Dec/2025
Tectonic Therapeutic USD 12.96M 3.29M Mar/2026
Telix Pharmaceuticals AUD 231.62M 66.96M Dec/2025
Viatris USD 6.81B 284M Mar/2026
Xeris Pharmaceuticals USD 118.59M 9.02M Mar/2026